WU Qiong,YU Hong-hong,LUO Rui-xi,et al.Total Glucosides of Paeony Improve Renal Injury in Mice with Systemic Lupus Erythematosus by Regulating TLR9/MyD88/NF-κB Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(12):103-110.
WU Qiong,YU Hong-hong,LUO Rui-xi,et al.Total Glucosides of Paeony Improve Renal Injury in Mice with Systemic Lupus Erythematosus by Regulating TLR9/MyD88/NF-κB Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(12):103-110. DOI: 10.13422/j.cnki.syfjx.20221239.
Total Glucosides of Paeony Improve Renal Injury in Mice with Systemic Lupus Erythematosus by Regulating TLR9/MyD88/NF-κB Pathway
B p65蛋白表达;蛋白免疫印迹法(Western blot)检测肾、脾组织中TLR9、MyD88、NF-
κ
B p65蛋白的表达水平。
结果
2
与空白组比较,模型组小鼠SCr、BUN及脾脏指数和肾脏指数明显升高(
P
<
0.05),肾组织病理损伤和纤维化程度明显增强;血清IFN-
α
、IL-4及ANA水平显著升高,IL-2水平明显降低(
P
<
0.05);肾脏和脾脏中TLR9、MyD88及NF-
κ
B p65的mRNA和蛋白水平明显升高(
P
<
0.05)。与模型组比较,TGP高、低剂量组小鼠SCr、BUN及脾脏指数和肾脏指数明显降低(
P
<
0.05),肾组织病理损伤和纤维化程度明显减轻;血清IFN-
α
、IL-4及ANA水平明显下降(
P
<
0.05),IL-2水平明显升高;肾脏和脾脏组织中TLR9、MyD88和NF-
κ
B p65等分子mRNA和蛋白表达水平均明显降低(
P
<
0.05)。
结论
2
TGP可能通过调控TLR9/MyD88/NF-
κ
B信号通路,进而抑制其下游相关炎症因子表达,发挥免疫调节及抗SLE肾脏损伤作用。
Abstract
Objective
2
To investigate the intervention effect of total glucosides of paeony (TGP) on the renal injury of MRL/lpr mice based on the Toll-like receptor 9 (TLR9)/myeloid differentiation factor 88 (MyD88)/nuclear transcription factor-
κ
B (NF-
κ
B) signaling pathway and explore the immunological mechanism of TGP in preventing and treating systemic lupus erythematosus (SLE).
Method
2
MRL/lpr female mice of SPF grade were randomly divided into a model group, a dexamethasone group (0.15 g·kg
-1
), and high- (0.078 g·kg
-1
) and low-dose (0.039 g·kg
-1
) TGP groups, and female C57BL/6J mice were assigned to a blank group, with 7 mice in each group. Mice in each group were treated with corresponding drugs or normal saline by gavage at the same time every day. After 4 weeks, samples were collected. The kidney and spleen were weighed, and the organ index was calculated. Serum creatinine (SCr) and blood urea nitrogen (BUN) levels in each group were detected by biochemical assay. Hematoxylin-eosin (HE) staining was used to observe the histopathological changes in the kidney. The degree of renal fibrosis was evaluated by Masson staining. The serum levels of interleukin (IL)-2, interferon (IFN)-
α
, IL-4, and anti-nuclear antibody (ANA) were detected by enzyme-linked immunosorbent assay (ELISA). The mRNA expression of TLR9, MyD88, and NF-
κ
B p65 in renal tissues was detected by real-time quantitative polymerase chain reaction (Real-time PCR). The protein expression of TLR9 and NF-
κ
B p65 in renal tissues was detected by immunofluorescence. The protein expression of TLR9, MyD88, and NF-
κ
B p65 in renal and spleen tissues was tested by Western blot.
Result
2
Compared with the blank group, the model group showed increased SCr, BUN, spleen index, and kidney index (
P
<
0.05), deteriorated pathological injury and fibrosis in renal tissues, elevated serum levels of IFN-
α
, IL-4, and ANA, decreased level of IL-2 (
P
<
0.05), and up-regulated TLR9, MyD88, and NF-
κ
B p65 mRNA and protein levels in the kidney and spleen (
P
<
0.05). Compared with the model group, the TGP groups displayed reduced SCr, BUN, spleen index, and kidney index (
P
<
0.05), relieved pathological damage and fibrosis in renal tissues, decreased serum levels of IFN-
α
, IL-4, and ANA (
P
<
0.05), increased level of IL-2, and declining mRNA and protein expression levels of TLR9, MyD88, and NF-
κ
B p65 in the kidney and spleen (
P
<
0.05).
Conclusion
2
TGP may inhibit the expression of downstream inflammatory factors to regulate immunity and resist SLE-induced renal injury by regulating the TLR9/MyD88/NF-
ZHANG L , WEI W . Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony [J]. Pharmacol Ther , 2020 , 207 : 107452 .
XIANG N , LI X M , ZHANG M J , et al . Total glucosides of paeony can reduce the hepatotoxicity caused by Methotrexate and Leflunomide combination treatment of active rheumatoid arthritis [J]. Int Immunopharmacol , 2015 , 28 ( 1 ): 802 - 807 .
LI X L , ZHANG Z , ZHANG H . Expression level of TLR9,but not hypomethylation,is correlated with SLE disease activity [J]. Physiol Res , 2019 , 68 ( 6 ): 973 - 980 .
JIAO Z F , ZHANG Y M , MA X F , et al . Correlation analysis of TLR9 and IL-23 expression in patients with lupus nephritis [J]. Eur Rev Med Pharmacol Sci , 2019 , 23 ( 7 ): 2944 - 2949 .
LI B , LIU G , LIU R , et al . Total glucosides of paeony (TGP) alleviates Sjogren's syndrome through inhibiting inflammatory responses in mice [J]. Phytomedicine , 2020 , 71 : 153203 .
DE CEUNINCK F , DUGUET F , AUSSY A , et al . IFN- α :A key therapeutic target for multiple autoimmune rheumatic diseases [J]. Drug Discov Today , 2021 , 26 ( 10 ): 2465 - 2473 .
MOHAMMADOO-KHORASANI M , SALIMI S , TABATABAI E , et al . Interleukin-1 β (IL-1 β ) & IL-4 gene polymorphisms in patients with systemic lupus erythematosus (SLE) & their association with susceptibility to SLE [J]. Indian J Med Res , 2016 , 143 ( 5 ): 591 - 596 .
SPEE-MAYER C , SIEGERT E , ABDIRAMA D , et al . Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus [J]. Ann Rheum Dis , 2016 , 75 ( 7 ): 1407 - 1415 .
PATRA M C , ACHEK A , KIM G Y , et al . A Novel small-molecule inhibitor of endosomal TLRs reduces inflammation and alleviates autoimmune disease symptoms in murine models [J]. Cells , 2020 , 9 ( 7 ): 1648 .
MORTEZAGHOLI S , BABALOO Z , RAHIMZADEH P , et al . Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN- α production in SLE patients [J]. Immunopharmacol Immunotoxicol , 2017 , 39 ( 1 ): 11 - 18 .
ELLOUMI N , FAKHFAKH R , ABIDA O , et al . Relevant genetic polymorphisms and kidney expression of Toll-like receptor (TLR)-5 and TLR-9 in lupus nephritis [J]. Clin Exp Immunol , 2017 , 190 ( 3 ): 328 - 339 .
YIM L , LAU C , CHAN V . Heightened TLR7/9-induced IL-10 and CXCL13 production with dysregulated NF- κ B activation in CD11c hi CD11b + dendritic cells in NZB/W F1 mice [J]. Int J Mol Sci , 2019 , 20 ( 18 ): 4639 - 4656 .
VINCENT G , JEAN-NICOLAS S , SOPHIE J , et al . Impaired TLR9 responses in B cells from patients with systemic lupus erythe-matosus [J]. JCI Insight , 2018 , 3 ( 5 ): 96795 - 96805 .